Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis

Authors

Michelle L Wegscheid, Washington University School of Medicine in St. Louis
Corina Anastasaki, Washington University School of Medicine in St. Louis
Kelly A Hartigan, Washington University School of Medicine in St. Louis
Olivia M Cobb, Washington University School of Medicine in St. Louis
Jason B Papke, Washington University School of Medicine in St. Louis
Jennifer N Traber, Washington University School of Medicine in St. Louis
Stephanie M Morris, Washington University School of Medicine in St. Louis
David H Gutmann, Washington University School of Medicine in St. Louis

Journal

Cell Reports

Publication Date

7-6-2021

Volume

36

Issue

1

First Page

109315

Document Type

Open Access Publication

DOI

10.1016/j.celrep.2021.109315

Rights and Permissions

Wegscheid ML, Anastasaki C, Hartigan KA, Cobb OM, Papke JB, Traber JN, Morris SM, Gutmann DH. Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis. Cell Rep. 2021 Jul 6;36(1):109315. doi: 10.1016/j.celrep.2021.109315. Copyright 2021 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Wegscheid, Michelle L; Anastasaki, Corina; Hartigan, Kelly A; Cobb, Olivia M; Papke, Jason B; Traber, Jennifer N; Morris, Stephanie M; and Gutmann, David H, "Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis." Cell Reports. 36, 1. 109315 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10629